Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleosome assembly protein 1-like 2, pseudogene (ENSG00000267088) is a non-coding genomic DNA sequence that resembles the protein-coding gene NAP1L2 but does not produce a functional protein product. Pseudogenes are considered non-functional remnants of genes that have accumulated mutations and are usually not transcribed or translated. This pseudogene is not associated with any known biological function, disease relevance, or therapeutic activity, and does not serve as a drug target[1][5][8]. For reference: the protein-coding gene "Nucleosome assembly protein 1-like 2" (NAP1L2, ENSG00000186462) is a member of the nucleosome assembly protein (NAP) family, involved in chromatin binding and regulation of neuronal cell proliferation[8]. However, the entity you specified (ENSG00000267088) is a pseudogene and thus does not encode that functional activity. Summary: “Nucleosome assembly protein 1-like 2, pseudogene” is not a valid therapeutic target; it is a non-functional pseudogene and should not be used as a target for drug or biomarker development[1][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleosome assembly protein 1-like 2, pseudogene.